4//SEC Filing
PharMerica CORP 4
Accession 0001209191-14-051914
CIK 0001388195operating
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 5:12 PM ET
Size
9.1 KB
Accession
0001209191-14-051914
Insider Transaction Report
Form 4
OAKLEY ROBERT A
Director
Transactions
- Sale
Common Stock, $0.01 par value
2014-08-08$26.55/sh−8,399$223,002→ 43,561 total - Exercise/Conversion
Common Stock, $0.01 par value
2014-08-08$16.16/sh+13,600$219,776→ 51,960 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-08-08−13,600→ 0 totalExercise: $16.16Exp: 2015-03-24→ Common Stock, $0.01 par value (13,600 underlying)
Footnotes (3)
- [F1]The shares were sold partially to cover the exercise cost of the options and the remaining shares were sold to cover the tax liability in connection with the exercise.
- [F2]Represents the weighted average purchase price for the transactions reported on this line. The range of prices for the transactions reported on this line was $26.5410 and $26.5680. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.
- [F3]The options vested in the following amounts on the following dates: 4,533 options on 03/24/2009, 4,533 options on 03/24/2010 and 4,534 options on 03/24/2011.
Documents
Issuer
PharMerica CORP
CIK 0001388195
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001388195
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 5:12 PM ET
- Size
- 9.1 KB